Vivimed Labs is currently trading at Rs. 140.00, up by 2.75 points or 2.00% from its previous closing of Rs. 137.25 on the BSE.
The scrip opened at Rs. 137.50 and has touched a high and low of Rs. 142.00 and Rs. 137.05 respectively. So far 98901 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 153.30 on 21-Sep-2017 and a 52 week low of Rs. 81.75 on 26-Sep-2016.
Last one week high and low of the scrip stood at Rs. 153.30 and Rs. 113.75 respectively. The current market cap of the company is Rs. 1151.91 crore.
The promoters holding in the company stood at 36.05%, while Institutions and Non-Institutions held 5.50% and 58.45% respectively.
Vivimed Labs has signed definitive agreements to facilitate an investment of $42.5 million by OrbiMed Asia into the Company’s subsidiary, Vivimed Labs Mascarene, the holding entity of the company’s API business, UQUIFA.
The proceeds of this fund raise will be utilized by the company primarily for Debt reduction and optimization of capital structure at the parent entity level and investment in the API business for capacity augmentation and organic growth.
Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.
